PA8659601A1 - Procedimiento para la preparacion de alcoholes aminoetoxibencilicos - Google Patents

Procedimiento para la preparacion de alcoholes aminoetoxibencilicos

Info

Publication number
PA8659601A1
PA8659601A1 PA20068659601A PA8659601A PA8659601A1 PA 8659601 A1 PA8659601 A1 PA 8659601A1 PA 20068659601 A PA20068659601 A PA 20068659601A PA 8659601 A PA8659601 A PA 8659601A PA 8659601 A1 PA8659601 A1 PA 8659601A1
Authority
PA
Panama
Prior art keywords
alcohols
preparation
aminoetoxibencilic
procedure
aminoetoxibencial
Prior art date
Application number
PA20068659601A
Other languages
English (en)
Inventor
Pietro Allegrini
Giorgio Soriato
Giuseppe Barreca
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PA8659601A1 publication Critical patent/PA8659601A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA PROCEDIMIENTOS E INTERMEDIOS PARA LA PREPARACION DE ALCOHOLES AMINOETOXIBENCILICOS DE LA FORMULA I, QUE SIRVEN EN LA PRODUCCION DE COMPUESTOS FARMACEUTICOS UTILES.
PA20068659601A 2005-01-13 2006-01-11 Procedimiento para la preparacion de alcoholes aminoetoxibencilicos PA8659601A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64350505P 2005-01-13 2005-01-13

Publications (1)

Publication Number Publication Date
PA8659601A1 true PA8659601A1 (es) 2007-01-17

Family

ID=36570630

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20068659601A PA8659601A1 (es) 2005-01-13 2006-01-11 Procedimiento para la preparacion de alcoholes aminoetoxibencilicos

Country Status (21)

Country Link
US (2) US7375251B2 (es)
EP (1) EP1836155A2 (es)
JP (1) JP2008526969A (es)
KR (1) KR20070097502A (es)
CN (1) CN101107217A (es)
AR (1) AR055837A1 (es)
AU (1) AU2006205099A1 (es)
BR (1) BRPI0606659A2 (es)
CA (1) CA2593965A1 (es)
CR (1) CR9208A (es)
GT (1) GT200600010A (es)
IL (1) IL184193A0 (es)
MX (1) MX2007008450A (es)
NI (1) NI200700175A (es)
NO (1) NO20073276L (es)
PA (1) PA8659601A1 (es)
PE (1) PE20060874A1 (es)
RU (1) RU2007124069A (es)
SG (1) SG158860A1 (es)
TW (1) TW200637803A (es)
WO (1) WO2006076350A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120253038A1 (en) 2009-04-13 2012-10-04 Sandoz Ag Processes for the synthesis of bazedoxifene acetate and intermediates thereof
EP2794580A1 (en) * 2011-12-23 2014-10-29 Basf Se Process for manufacturing benzoxazinones
MX360806B (es) * 2012-08-17 2018-11-16 Basf Se Benzoxazinonas de carbamato.
AU2016288230A1 (en) 2015-07-02 2018-01-25 Horizon Orphan Llc ADO-resistant cysteamine analogs and uses thereof
CN107793344B (zh) * 2017-10-24 2021-01-12 扬子江药业集团有限公司 一种醋酸巴多昔芬的工业化生产方法
CN113816892A (zh) * 2021-08-27 2021-12-21 安徽鼎旺医药有限公司 一种醋酸巴多昔芬的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2003430C3 (de) 1969-01-31 1978-12-07 Laboratorien Fournier Gmbh, 6600 Saarbruecken p-Benzoylphenoxyisobuttersäureester, ihre Herstellung und diese enthaltende Arzneimittel
CH543472A (fr) * 1969-01-31 1973-10-31 Orchimed Sa Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
US3772356A (en) * 1970-03-26 1973-11-13 Lab Bruneau & Cie Phenoxy-acetamides
GB8919434D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
DE4438028A1 (de) 1994-10-25 1996-05-02 Thomae Gmbh Dr K Basisch substituierte N-Phenylalkyl- und N-Phenoxyalkylamide, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
US5998402A (en) 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US5929097A (en) 1996-10-16 1999-07-27 American Cyanamid Company Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
IL135343A0 (en) * 1997-10-15 2001-05-20 American Home Prod Novel aryloxy-alkyl-dialkylamines
US6005102A (en) 1997-10-15 1999-12-21 American Home Products Corporation Aryloxy-alkyl-dialkylamines
DE10146867A1 (de) * 2001-09-24 2003-04-24 Bayer Ag Tetrahydroisochinoline
MXPA05008878A (es) * 2003-02-21 2005-10-05 Pfizer Derivados de aminotiazol sustituidos con cicloalquilo que contiene n y composiciones farmaceuticas para inhibir la proliferacion celular, y metodos para su uso.

Also Published As

Publication number Publication date
PE20060874A1 (es) 2006-10-16
NO20073276L (no) 2007-09-04
MX2007008450A (es) 2007-08-06
US7375251B2 (en) 2008-05-20
BRPI0606659A2 (pt) 2009-07-07
CN101107217A (zh) 2008-01-16
WO2006076350A3 (en) 2007-03-01
EP1836155A2 (en) 2007-09-26
US20060155147A1 (en) 2006-07-13
GT200600010A (es) 2006-08-16
WO2006076350A2 (en) 2006-07-20
RU2007124069A (ru) 2009-02-20
TW200637803A (en) 2006-11-01
SG158860A1 (en) 2010-02-26
AU2006205099A1 (en) 2006-07-20
CR9208A (es) 2007-10-23
KR20070097502A (ko) 2007-10-04
IL184193A0 (en) 2007-10-31
JP2008526969A (ja) 2008-07-24
AR055837A1 (es) 2007-09-12
CA2593965A1 (en) 2006-07-20
US20080207898A1 (en) 2008-08-28
NI200700175A (es) 2008-05-09

Similar Documents

Publication Publication Date Title
CR8929A (es) Polimorfo ii de rapamicina y usos del mismo
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
HN2006037713A (es) Compuestos utiles en terapia
ATE528989T1 (de) Kristalline feste rasagilin-base
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
PA8667201A1 (es) Nuevos compuestos farmaceuticos
CL2007003797A1 (es) Compuestos derivados de pirrolo piridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la enfermedad de alzheimer, parkinson, cancer, entre otras enfermedades.
PA8660301A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
GT200800155A (es) Metodos para preparar alcoholes de sulfonamida sustituidos e intermediarios
CR10157A (es) Compuestos químicos
DOP2005000025A (es) Compuestos de heteroaril- y fenilsulfamoilo sustituidos
AR053334A1 (es) Pirazolilcarboxanilidas
UY30460A1 (es) Compuestos terapéuticos
BRPI0911577A2 (pt) derivados espiro-indol para o tratamento de doenças parasíticas.
ECSP066822A (es) Macrólidos y métodos para producir los mismos
HN2006029142A (es) Proceso
BRPI0519710A2 (pt) aminoÁlcoois tricÍclicos, processo para sua preparaÇço e seu emprego como anti-inflamatàrio
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
CR10548A (es) 18-metil-19nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas) asi como preparaciones farmaceuticas que los contienen
CR9872A (es) Diazepinoquinolinas, su sintesis e intermediarios
PA8659601A1 (es) Procedimiento para la preparacion de alcoholes aminoetoxibencilicos
PA8624401A1 (es) Procesos para la preparacion de haluros de aril- y heteroaril-alquilsulfonilo
GT200600349A (es) Compuestos orgánicos
ECSP088151A (es) Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas